Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)

HKD 1.39

(-0.71%)

Market Cap (In HKD)

800.99 Million

Revenue (In HKD)

841.54 Million

Net Income (In HKD)

148.2 Million

Avg. Volume

46.09 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.21-1.95
PE
-
EPS
-
Beta Value
0.024
ISIN
CNE100000130
CUSIP
Y44430109
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Hong Zhang
Employee Count
-
Website
https://www.jlchanglong.com
Ipo Date
2001-05-24
Details
Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People's Republic of China. It offers tablets, capsules, pills, Chinese medicine pretreatment and extraction products, powders for injections, lyophilized powder for injections, small volume injection solutions, APIs, and granules. The company markets its products under the Changlong and Qing Tong brands. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.